tetradecanoylphorbol acetate has been researched along with hydroxychloroquine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Betts, WH; French, JK; Gorjatschko, L; Hurst, NP | 1 |
Bell, AL; Betts, WH; Cleland, LG; French, JK; Hurst, NP; Nuki, G; O'Donnell, ML | 1 |
Gilman, AL; Goldman, FD; Hollenback, C; Kato, RM; Premack, BA; Rawlings, DJ | 1 |
3 other study(ies) available for tetradecanoylphorbol acetate and hydroxychloroquine
Article | Year |
---|---|
Chloroquine and hydroxychloroquine inhibit multiple sites in metabolic pathways leading to neutrophil superoxide release.
Topics: Cells, Cultured; Chloroquine; Fluorides; Humans; Hydroxychloroquine; Neutrophils; Receptors, Complement; Receptors, Complement 3b; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1988 |
Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes.
Topics: Arachidonic Acid; Arachidonic Acids; Calcimycin; Cell Survival; Chloroquine; Fluorides; Humans; Hydroxychloroquine; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Phospholipids; Quinacrine; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1986 |
Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties.
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Calcium; Gene Expression Regulation; Humans; Hydroxychloroquine; Immunosuppressive Agents; Inositol Phosphates; Jurkat Cells; Kinetics; Lectins, C-Type; Receptors, Antigen, T-Cell; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 2000 |